Literature DB >> 29487816

Correlation between macular ganglion cell-inner plexiform layer thickness and visual acuity after resolution of the macular edema secondary to central retinal vein occlusion.

Hyun Ju Kim1, Han Gyul Yoon1, Seong Taeck Kim1.   

Abstract

AIM: To examine the thickness of the ganglion cell-inner plexiform layer (GCIPL) in eyes with resolved macular edema (ME) in non-ischemic central retinal vein occlusion (CRVO), applying spectral-domain optical coherence tomography (SD-OCT), and its relationship with visual acuity.
METHODS: The retrospective observational case-control study included 30 eyes of non-ischemic CRVO patients with resolved ME (ME eyes) after treatment, and 30 eyes of non-ischemic CRVO patients without ME (non-ME eyes). The macular GCIPL thickness, peripapillary retinal nerve fiber layer (pRNFL) thickness and central macular thickness (CMT) were measured on a SD-OCT scan. Linear regression analyses were performed to determine the correlation between the thickness of each and the visual acuity (VA).
RESULTS: No significant difference in average GCIPL thickness, mean pRNFL thickness and CMT were observed between ME group and non-ME group (P=0.296, 0.183, 0.846). But, minimum GCIPL thickness was reduced in ME eyes compared with non-ME eyes (P=0.022). Final VA significantly correlated with the minimum GCIPL thickness in ME eyes (r=-0.482, P=0.007), whereas no correlation was found with average GCIPL thickness, average pRNFL thickness and mean CMT.
CONCLUSION: Minimum GCIPL thickness is reduced in ME eyes compared with non-ME eyes, and correlated with the VA in non-ischemic CRVO. These results propose that inner retinal damage occurring in patients with ME secondary to non-ischemic CRVO may lead to permanent visual defect after treatment.

Entities:  

Keywords:  central retinal vein occlusion; ganglion cell-inner plexiform layer; optical coherence tomography

Year:  2018        PMID: 29487816      PMCID: PMC5824081          DOI: 10.18240/ijo.2018.02.13

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  29 in total

1.  Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion.

Authors:  Michael S Ip; K S Kumar
Journal:  Arch Ophthalmol       Date:  2002-09

2.  Short-term effects of a single intravitreal bevacizumab injection on retinal vessel calibre.

Authors:  Sinan Tatlipinar; Umut Aslı Dinç; N Melda Yenerel; Ebru Görgün
Journal:  Clin Exp Optom       Date:  2011-09-28       Impact factor: 2.742

3.  Retinal nerve fiber layer thickness reproducibility using seven different OCT instruments.

Authors:  Luisa Pierro; Marco Gagliardi; Lorenzo Iuliano; Alessandro Ambrosi; Francesco Bandello
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-31       Impact factor: 4.799

4.  Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study.

Authors:  David M Brown; Peter A Campochiaro; Rishi P Singh; Zhengrong Li; Sarah Gray; Namrata Saroj; Amy Chen Rundle; Roman G Rubio; Wendy Yee Murahashi
Journal:  Ophthalmology       Date:  2010-04-09       Impact factor: 12.079

5.  Electrophysiologic findings after intravitreal bevacizumab (Avastin) treatment.

Authors:  Raj K Maturi; Laura A Bleau; Donald L Wilson
Journal:  Retina       Date:  2006-03       Impact factor: 4.256

6.  Intravitreal bevacizumab for treatment of macular edema secondary to central retinal vein occlusion: eighteen-month results of a prospective trial.

Authors:  Han Zhang; Zhe-Li Liu; Peng Sun; Feng Gu
Journal:  J Ocul Pharmacol Ther       Date:  2011-08-08       Impact factor: 2.671

7.  Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF.

Authors:  R G Tilton; K C Chang; W S LeJeune; C C Stephan; T A Brock; J R Williamson
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-03       Impact factor: 4.799

8.  Pathology of human cystoid macular edema.

Authors:  M Yanoff; B S Fine; A J Brucker; R C Eagle
Journal:  Surv Ophthalmol       Date:  1984-05       Impact factor: 6.048

9.  Intravitreal bevacizumab treatment of macular edema in central retinal vein occlusion: one-year results.

Authors:  Julia Beutel; Focke Ziemssen; Matthias Lüke; Michael Partsch; Karl-Ulrich Bartz-Schmidt; Faik Gelisken
Journal:  Int Ophthalmol       Date:  2008-12-20       Impact factor: 2.031

10.  VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma.

Authors:  Richard H Foxton; Arthur Finkelstein; Sauparnika Vijay; Annegret Dahlmann-Noor; Peng T Khaw; James E Morgan; David T Shima; Yin-Shan Ng
Journal:  Am J Pathol       Date:  2013-02-12       Impact factor: 4.307

View more
  2 in total

1.  Comparison of Each Retinal Layer Thicknesses between Eyes with Central Retinal Vein Occlusion and Normal Contralateral Eyes.

Authors:  Hwa Young Yu; Min Woo Lee; Jung Tae Kim; Sung Chul Lee; Young Hoon Lee
Journal:  Korean J Ophthalmol       Date:  2022-05-06

2.  Relief of Cystoid Macular Edema-Induced Focal Axonal Compression with Anti-Vascular Endothelial Growth Factor Treatment.

Authors:  Eyyup Karahan; Aliaa Abdelhakim; Ceren Durmaz; Tongalp H Tezel
Journal:  Transl Vis Sci Technol       Date:  2020-03-18       Impact factor: 3.283

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.